Yumanity Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Kineta

15/11/2021 22:01

* Yumanity Therapeutics Inc  YMTX.OQ  reported a quarterly
adjusted loss of 97 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of $1.13 per share.
* Revenue was $1.64 million​;  analysts expected $1.93 million. 
* Yumanity Therapeutics Inc's reported EPS for the quarter was a
loss of 97 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Yumanity Therapeutics Inc shares had fallen by 49.1% this
quarter and lost 69.1% so far this year.
* The company reported a quarterly loss of $9.96 million.
* Wall Street's median 12-month price target for Yumanity
Therapeutics Inc is $35.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 10:01 p.m.
 ​All figures in US dollars unless otherwise stated